Avantor Performance Materials, Nusil Technology to Merge
The merger of Avantor Performance Materials and Nusil Technology positions the company for growth in bioprocessing.
Avantor Performance Materials and NuSil Technology, portfolio companies of New Mountain Capital, announced on Aug. 31, 2016 an agreement to merge. The combined company, to be named Avantor, will provide performance materials and solutions for the production and research to more than 6500 customers in the biotechnology, pharmaceutical, medical device, diagnostics, aerospace and defense, and semiconductor industries.
The combination brings complementary technologies and advanced analytical capabilities to a portfolio of mor than 30,000 products; the company reports in a press announcement that it will be positioned to support the industrialization of the biopharmaceutical sector through its bioprocessing and biomaterials offerings with a focus on productivity and quality. Combined revenues will be over $700 million, growing at 14% per year.
New Mountain is the majority owner of both companies, and will remain as the majority owner post-merger. The merger is expected to close in late September. Terms of the transaction were not disclosed.
Source: Avantor Performance Materials
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development
March 26th 2024In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.
Entering New Domains for 3D Printing of Drug Products
April 6th 20253D printing of personalized medications is currently possible under existing compounding regulations, offering enhanced process control through automation. But new legislation coming in 2025 will allow 3D printing as part of a distributed manufacturing framework.
